ATGC holds key technologies that empower us to develop innovative products and offer cutting edge services.    

- Gene editing technology miCas9

- Monoclonal antibody platform SBEAD

- Embryonic stem cells       

Services

Monoclonal antibody development   

 

Antigen design, peptide synthesis and conjugation

 

Antibody humanization

 

Biological conjugation of antibody

 

Animal embryo cryopreservation

 

Transgenic animal production